Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Yellowknifer69on Apr 07, 2021 8:30am
197 Views
Post# 32947813

Yesterday's Trades

Yesterday's TradesHello and good morning Ate Longs:

Just taking a moment to catch up on all things not related to Covid!  (which is hard to do these days)

In any case, I note the high degree (once again) of dissatisfaction with the Dan, Stern, and Co.  For the record, yesterday's global trade volume was the lowest on record for the year.  All the markets are down at the moment.  

Investment firms are likely hedging their bets, saving any liquid assets, and waiting for the next FeD move from the U.S.  

Stay long,  I am of the opinion that something terrific is brewing at ATE but sometimes great things take a bit longer to make.

In the meantime, go out there and enjoy your life - drink expensive beer, stay connected, etc.  Life is short so make it sweet folks!

Lets get it rolling Dan - show us the money!

Yellowknifer
<< Previous
Bullboard Posts
Next >>